SCHEMBL1642054

SCHEMBL1642054

CC(C)(C)C(=O)Nc1cnccc1C(=O)c1cccc(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.46
ABCC9 O60706 1/20 0.45
ABCC8 Q09428 1/20 0.45
KCNJ11 Q14654 1/20 0.45
KCNJ8 Q15842 1/20 0.45
KDM4D Q6B0I6 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
TSHR P16473 2/20 0.43
BRAF P15056 1/20 0.43
BDKRB1 P46663 1/20 0.42
CSF1R P07333 1/20 0.40
NPY2R P49146 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
RAB9A P51151 2/20 0.39
NPC1 O15118 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643403 0.87 NT5E (0.47) NPSR1KDM4DKDM4CTSHRBRAF
SCHEMBL2081422 0.86 TSHR (0.49) NPSR1TSHRBRAFCSF1RKMT2A
SCHEMBL1643182 0.85 KDM4C (0.56) NPSR1KDM4DKDM4CTSHRKMT2A
SCHEMBL1643097 0.82 TSHR (0.41) KDM4CTSHRBDKRB1KMT2ARAB9A
SCHEMBL1643694 0.81 HPGD (0.40) TSHRKMT2AMEN1RAB9ANPC1
SCHEMBL2081210 0.78 NPC1 (0.43) KDM4DKDM4CTSHRRAB9ANPC1
SCHEMBL4137818 0.76 CES2 (0.49) BRAFCSF1RTAAR1KMT2AMEN1
SCHEMBL6644009 0.75 LTA4H (0.46) ABCC9ABCC8KCNJ11KCNJ8TSHR
SCHEMBL1643132 0.74 ALDH1A1 (0.48) TSHRNPY2RTAAR1RAB9ANPC1
SCHEMBL1644026 0.74 TSHR (0.51) KDM4DKDM4CTSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110098298-A1 New Pyridin-3-Amine Derivatives LABORATORIOS ALMIRALL, S.A. (ES) 2011-04-28 US disclosed
EP-1987005-A2 NEW PYRIDIN-3-AMINE DERIVATIVES Laboratorios Almirall, S.A. (ES) 2008-11-05 EP disclosed
WO-2007096072-A2 NEW PYRIDIN-3-AMINE DERIVATIVES LABORATORIOS ALMIRALL, S.A. (ES) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098298-A1 New Pyridin-3-Amine Derivatives MAPK1, MAP4K2, MAPK3 NPSR1 2957/4885ABCC9 3315/4885ABCC8 2806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.